nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—Paraesthesia—Fludarabine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Cilazapril—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Cilazapril—Dyspnoea—Fludarabine—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Cilazapril—Dyspepsia—Fludarabine—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Cilazapril—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Cilazapril—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Cilazapril—Decreased appetite—Fludarabine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Cilazapril—Visual impairment—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Cilazapril—Fatigue—Fludarabine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Cilazapril—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Cilazapril—Constipation—Fludarabine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cilazapril—Pain—Fludarabine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cilazapril—Bradycardia—Mitoxantrone—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cilazapril—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Cilazapril—Urethral disorder—Vincristine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Cilazapril—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Cilazapril—Hypersensitivity—Teniposide—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Cilazapril—Flushing—Carmustine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Cilazapril—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cilazapril—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Cilazapril—Anaemia—Bleomycin—lymphatic system cancer	0.00204	0.00204	CcSEcCtD
Cilazapril—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Cilazapril—Asthenia—Teniposide—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cilazapril—Malaise—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Cilazapril—Pruritus—Teniposide—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cilazapril—Arrhythmia—Carmustine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cilazapril—Leukopenia—Bleomycin—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Cilazapril—Cardiac disorder—Vincristine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Cilazapril—Alopecia—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Cilazapril—Cough—Bleomycin—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Cilazapril—Angiopathy—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Cilazapril—Diarrhoea—Teniposide—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Cilazapril—Chest pain—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Cilazapril—Myalgia—Bleomycin—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Cilazapril—Alopecia—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Cilazapril—Discomfort—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cilazapril—Chills—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cilazapril—Urine output increased—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cilazapril—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cilazapril—Alopecia—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cilazapril—Confusional state—Bleomycin—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Cilazapril—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Cilazapril—Tremor—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Cilazapril—Oedema—Bleomycin—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Cilazapril—Anaemia—Carmustine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cilazapril—Vomiting—Teniposide—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cilazapril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cilazapril—Asthenia—Fludarabine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cilazapril—Rash—Teniposide—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Cilazapril—Dermatitis—Teniposide—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cilazapril—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cilazapril—Headache—Teniposide—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cilazapril—Pruritus—Fludarabine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Cilazapril—Leukopenia—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Cilazapril—Anorexia—Bleomycin—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cilazapril—Anaemia—Vincristine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Cilazapril—Photosensitivity—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cilazapril—Polyuria—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cilazapril—Hypotension—Bleomycin—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Cilazapril—Diarrhoea—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Cilazapril—Hypertension—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Cilazapril—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cilazapril—Nausea—Teniposide—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cilazapril—Anaemia—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cilazapril—Vertigo—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cilazapril—Leukopenia—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cilazapril—Chest pain—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cilazapril—Myalgia—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cilazapril—Anxiety—Carmustine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Cilazapril—Paraesthesia—Bleomycin—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cilazapril—Malaise—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cilazapril—Dyspnoea—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cilazapril—Renal failure acute—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cilazapril—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Cilazapril—Hypertension—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Cilazapril—Confusional state—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Cilazapril—Oedema—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Cilazapril—Decreased appetite—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cilazapril—Myalgia—Vincristine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cilazapril—Cough—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Cilazapril—Vomiting—Fludarabine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Cilazapril—Rash—Fludarabine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cilazapril—Dermatitis—Fludarabine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cilazapril—Hypertension—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Cilazapril—Pain—Bleomycin—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cilazapril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cilazapril—Headache—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cilazapril—Tachycardia—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cilazapril—Myalgia—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Cilazapril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Cilazapril—Chest pain—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Cilazapril—Anxiety—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Cilazapril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cilazapril—Discomfort—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Cilazapril—Oedema—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cilazapril—Anorexia—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cilazapril—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cilazapril—Confusional state—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Cilazapril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cilazapril—Hypotension—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Cilazapril—Oedema—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cilazapril—Nausea—Fludarabine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Cilazapril—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cilazapril—Shock—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cilazapril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cilazapril—Urticaria—Bleomycin—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cilazapril—Anorexia—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cilazapril—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Cilazapril—Insomnia—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cilazapril—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cilazapril—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Cilazapril—Paraesthesia—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cilazapril—Hypotension—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cilazapril—Dyspnoea—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cilazapril—Somnolence—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cilazapril—Anorexia—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cilazapril—Ataxia—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cilazapril—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cilazapril—Decreased appetite—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cilazapril—Hypotension—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Cilazapril—Insomnia—Vincristine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cilazapril—Paraesthesia—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cilazapril—Constipation—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cilazapril—Pain—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Cilazapril—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cilazapril—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Cilazapril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cilazapril—Decreased appetite—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cilazapril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Cilazapril—Somnolence—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cilazapril—Feeling abnormal—Carmustine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cilazapril—Fatigue—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Cilazapril—Asthenia—Bleomycin—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cilazapril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cilazapril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cilazapril—Pain—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cilazapril—Constipation—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Cilazapril—Pruritus—Bleomycin—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Cilazapril—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Cilazapril—Fatigue—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cilazapril—Pancreatitis—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Cilazapril—Constipation—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cilazapril—Pain—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cilazapril—Abdominal pain—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Cilazapril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cilazapril—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cilazapril—Neutropenia—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cilazapril—Dysuria—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cilazapril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cilazapril—Abdominal pain—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cilazapril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Cilazapril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cilazapril—Urticaria—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cilazapril—Hypersensitivity—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cilazapril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cilazapril—Vomiting—Bleomycin—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Cilazapril—Rash—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cilazapril—Dermatitis—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cilazapril—Asthenia—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cilazapril—Hypersensitivity—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cilazapril—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cilazapril—Asthenia—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cilazapril—Diarrhoea—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cilazapril—Nausea—Bleomycin—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cilazapril—Asthenia—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Cilazapril—Dizziness—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cilazapril—Diarrhoea—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cilazapril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Cilazapril—Vomiting—Carmustine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Cilazapril—Dizziness—Vincristine—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Cilazapril—Rash—Carmustine—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Cilazapril—Dermatitis—Carmustine—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—lymphatic system cancer	0.00099	0.00099	CcSEcCtD
Cilazapril—Headache—Carmustine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Cilazapril—Vomiting—Vincristine—lymphatic system cancer	0.000956	0.000956	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000953	0.000953	CcSEcCtD
Cilazapril—Rash—Vincristine—lymphatic system cancer	0.000948	0.000948	CcSEcCtD
Cilazapril—Dermatitis—Vincristine—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Cilazapril—Headache—Vincristine—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Cilazapril—Nausea—Carmustine—lymphatic system cancer	0.000936	0.000936	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Cilazapril—Vomiting—Mitoxantrone—lymphatic system cancer	0.000931	0.000931	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—lymphatic system cancer	0.000928	0.000928	CcSEcCtD
Cilazapril—Rash—Mitoxantrone—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Cilazapril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000922	0.000922	CcSEcCtD
Cilazapril—Chills—Methotrexate—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Cilazapril—Headache—Mitoxantrone—lymphatic system cancer	0.000917	0.000917	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Cilazapril—Nausea—Vincristine—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Cilazapril—Nausea—Mitoxantrone—lymphatic system cancer	0.00087	0.00087	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—lymphatic system cancer	0.000826	0.000826	CcSEcCtD
Cilazapril—Malaise—Methotrexate—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Cilazapril—Cough—Methotrexate—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000756	0.000756	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—lymphatic system cancer	0.000736	0.000736	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000714	0.000714	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—lymphatic system cancer	0.000709	0.000709	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—lymphatic system cancer	0.000695	0.000695	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—lymphatic system cancer	0.000682	0.000682	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000665	0.000665	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—lymphatic system cancer	0.00066	0.00066	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—lymphatic system cancer	0.000655	0.000655	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—lymphatic system cancer	0.00065	0.00065	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—lymphatic system cancer	0.000649	0.000649	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—lymphatic system cancer	0.000642	0.000642	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00063	0.00063	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—lymphatic system cancer	0.000629	0.000629	CcSEcCtD
Cilazapril—Pain—Methotrexate—lymphatic system cancer	0.000624	0.000624	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000597	0.000597	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000538	0.000538	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—lymphatic system cancer	0.000523	0.000523	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000499	0.000499	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—lymphatic system cancer	0.000482	0.000482	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—lymphatic system cancer	0.000464	0.000464	CcSEcCtD
Cilazapril—Rash—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—lymphatic system cancer	0.00046	0.00046	CcSEcCtD
Cilazapril—Headache—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Cilazapril—Nausea—Methotrexate—lymphatic system cancer	0.000433	0.000433	CcSEcCtD
